Excision BioTherapeutics

excision.bio

The startup develops gene editing therapeutics that target and disrupt viral genes associated with neurotrophic viruses, transforming them into safe and effective treatments. This enables healthcare providers to effectively manage diseases caused by viral infections, improving patient outcomes.

Traction 10/10

San Francisco, United States · HQ

Founded 2015393K+ followers

Biotechnology

Updated 6 months ago

Funding

Raised to date

$82MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Ben Kong

Founder First Block Ventures, Angel Investor in 100+ companies. Space, Biotech, Web 3, Metaverse, NFT

Product

Features

The startup develops gene editing therapeutics that target and disrupt viral genes associated with neurotrophic viruses, transforming them into safe and effective treatments. This enables healthcare providers to effectively manage diseases caused by viral infections, improving patient outcomes.